Exendin-4 (Heloderma suspectum) – Fluorescent EIA Kit

Catalog #: FEK-070-94

Size: 96 wells

Price: $655

Intra-assay variation: <10%
Inter-assay variation: <15%

Linear Range: 11.2 – 273 pg/ml

Sensitivity: 11.2 pg/ml

Sample Extraction: Recommended

Absorption: 325 nm

Max Emissions: 420 nm

Cross Reactivity:

*Peptide*	%
Exendin-4 (Heloderma Suspectum)	100
Exendin-3 (9-39)-NH2	100
Exendin-4 (3-39)	100
Lixisenatide	100
Glucagon (Human, Rat, Mouse, Porcine, Bovine)	0
GLP-1 (7-36)-NH2 (Human, Rat, Mouse)	0
GLP-1 (7-37) (Human, Rat, Mouse)	0
GLP-2 (Human)	0
Oxyntomodulin (Human, Rat, Mouse)	0

Standard Curve:

Disclaimer: To reduce background noise for this kit, do not add EDTA to your samples.Heparin can be used as an alternative to EDTA for this kit.

No results found.

Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet.
Athauda D, Maclagan K, Skene SS, et al. 2017;390(10103):1664-1675.

Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus.
Wang Y, Xu B, Zhu L, et al. Clin Drug Investig. 2017;37(12):1107-1115.

A noncytolytic antibody-like extendin-4-IgG4 fusion protein as a long-acting potential anti-diabetic agent.
Li X, Hu P, Yang R, et al. International Journal of Clinical and Experimental Medicine. 2015;8(3):3607-3618.

Combination of ELISA and dried blood spot technique for the quantification of large molecules using exenatide as a model.
Lin YQ, Khetarpal R, Zhang Y, Song H, Li SS. J Pharmacol Toxicol Methods. 2011;64(2):124-8.

Your Cart